Carcinoma Clinical Trials

239 clinical trials for Carcinoma across international registries, including 33 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors — RECRUITING · PHASE1
• Collection of Blood and Urine From Patients Undergoing Radiation Therapy — RECRUITING
• Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer — RECRUITING · PHASE2
• Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC — RECRUITING · PHASE2
• Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer — RECRUITING
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) — RECRUITING · PHASE1
• Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma — RECRUITING · PHASE1
• Anatomical-Clinical Base of Adenocarcinoma Pancreatic — RECRUITING
• Registry Platform Ovarian and Endometrial Cancer — RECRUITING
• Study to Evaluate the Safety and Efficacy of Oral NRC-2694-A in Combination With Paclitaxel in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma, Who Progressed on or After Immune Checkpoint Inhibitor Therapy — RECRUITING · PHASE2
• Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study) — RECRUITING
• Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma — RECRUITING
• A Single-arm Phase II Clinical Study Investigating the Safety and Efficacy of Carbon Ion Radiotherapy in Patients With Hepatocellular Carcinoma Previously Treated With Transarterial Radioembolization (TARE) — RECRUITING · NA
• A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma — RECRUITING · PHASE2
• SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry — RECRUITING
• Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan — RECRUITING
• Safety and Efficacy of Pucotenlimab in pLECC — RECRUITING · PHASE2
• Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study — RECRUITING
• A Study of RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma — RECRUITING · PHASE2
• Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067 — RECRUITING · PHASE1
• A PHASE 2, OPEN-LABEL, RANDOMIZED STUDY OF LIVMONIPLIMAB IN COMBINATION WITH BUDIGALIMAB VERSUS CHEMOTHERAPY IN SUBJECTS WITH METASTATIC UROTHELIAL CARCINOMA — RECRUITING · PHASE2
• Beyond TME Origins — RECRUITING · NA
• A RANDOMIZED PHASE II, DOUBLE-BLIND, MULTICENTER STUDY OF AUTOGENE CEVUMERAN PLUS NIVOLUMAB VERSUS PLACEBO PLUS NIVOLUMAB AS ADJUVANT THERAPY IN PATIENTS WITH HIGH-RISK MUSCLE-INVASIVE UROTHELIAL CARCINOMA — RECRUITING · PHASE2
• Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin — RECRUITING · PHASE2
• An Exploratory Clinical Study Evaluating the Safety and Efficacy of Anti-CEA-CAR-T Cells Injection in Patients With CEA+ Locally Advanced and/or Metastatic Solid Tumors — RECRUITING · PHASE1
• A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE-COMPARATOR-CONTROLLED CLINICAL STUDY OF ADJUVANT V940 (MRNA-4157) PLUS PEMBROLIZUMAB VERSUS ADJUVANT PLACEBO PLUS PEMBROLIZUMAB IN PARTICIPANTS WITH HIGH-RISK MUSCLE-INVASIVE UROTHELIAL CARCINOMA POST-RADICAL RESECTION — RECRUITING · PHASE2
• XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma — RECRUITING · PHASE2
• A PHASE II STUDY OF FLUORINE-148 (18F)-LABELED PSMA-1007 IN PATIENTS WITH KNOWN OR SUSPECTED METASTATIC PROSTATIC CARCINOMA — RECRUITING · PHASE2
• Propofol vs Sevo for Paediatric Tumor Surgery — RECRUITING · PHASE4
• "A PHASE 3 RANDOMIZED, DOUBLE BLIND STUDY OF PEMBROLIZUMAB PLUS GEMCITABINE/CISPLATIN VERSUS PLACEBO PLUS GEMCITABINE/CISPLATIN AS FIRST-LINE THERAPY IN PARTICIPANTS WITH ADVANCED AND/OR UNRESECTABLE BILIARY TRACT CARCINOMA. — RECRUITING · PHASE3
• A PHASE 1 A/2A COHORT DOSE ESCALATION TRIAL TO DETERMINE THE SAFETY, TOLERANCE, MAXIMUM TOLERATED DOSE AND PRELIMINARY ANTINEOPASTIC ACTIVITY OF AVID100, AN ANTI-HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR MONOCLONAL ANTIBODY LINKED TO THE MAYTANSINOID OM 1 — RECRUITING · PHASE1
• A PHASE 1 STUDY OF ASP8374, AN IMMUNE CHECKPOINT INHIBITOR, AS A SINGLE AGENT IN SUBJECTS WITH LOCALLY ADVANCED OR METASTATIC CARCINOMA — RECRUITING · PHASE1
• A MULTI-CENTRE, SINGLE ARM, PHASE 2 TRIAL OF PEMBROLIZUMAB IN TREATMENT NAIVE PATIENTS WITH POOR PROGNOSIS CARCINOMA OF UNKNOWN PRIMARY SITE — RECRUITING · PHASE2
• Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance — NOT_YET_RECRUITING · PHASE2
• Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck — ACTIVE_NOT_RECRUITING · PHASE2
• Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer — TERMINATED · PHASE1
• Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment — ACTIVE_NOT_RECRUITING · PHASE3
• Study of XNW5004 Tablet in Combination With KEYTRUDA® (Pembrolizumab) in Subjects With Advanced Solid Tumors Who Failed Standard Treatments (KEYNOTE F19) — TERMINATED · PHASE1
• Savolitinib vs. Sunitinib in MET-driven PRCC. — ACTIVE_NOT_RECRUITING · PHASE3
• Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular Profiling — ACTIVE_NOT_RECRUITING
• Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery — COMPLETED · PHASE2
• Canadian Initiative to Measure, Predict and Assess Cancer Treatment Outcomes in Patients Treated With Immuno-Oncotherapeutics — NOT_YET_RECRUITING
• A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101) — COMPLETED · PHASE1
• Evaluation of 68-GaNOTA-Anti-HER2 VHH1 Uptake in Brain Metastasis of Cancer Patients — TERMINATED · PHASE2
• Impact of Body Composition on Dosimetry of 177Lu-PSMA Radioligand Therapy — NOT_YET_RECRUITING · NA
• MRinRT: Swansea University and SWWCC Collaboration Study. — NOT_YET_RECRUITING
• Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer — ACTIVE_NOT_RECRUITING · NA
• Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer — TERMINATED · NA
• B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults — ACTIVE_NOT_RECRUITING · PHASE1
• Osimertinib Plus Savolitinib in EGFRm+/MET+ NSCLC Following Prior Osimertinib — ACTIVE_NOT_RECRUITING · PHASE2

Refine this search